JP2011516032A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516032A5 JP2011516032A5 JP2010548899A JP2010548899A JP2011516032A5 JP 2011516032 A5 JP2011516032 A5 JP 2011516032A5 JP 2010548899 A JP2010548899 A JP 2010548899A JP 2010548899 A JP2010548899 A JP 2010548899A JP 2011516032 A5 JP2011516032 A5 JP 2011516032A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- gastric cancer
- composition
- biomarker
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 27
- 206010017758 gastric cancer Diseases 0.000 claims 27
- 201000011549 stomach cancer Diseases 0.000 claims 27
- 238000000034 method Methods 0.000 claims 23
- 108091045790 miR-106b stem-loop Proteins 0.000 claims 21
- 108091085564 miR-25 stem-loop Proteins 0.000 claims 20
- 108091080167 miR-25-1 stem-loop Proteins 0.000 claims 20
- 108091083056 miR-25-2 stem-loop Proteins 0.000 claims 20
- 108091032902 miR-93 stem-loop Proteins 0.000 claims 20
- 230000014509 gene expression Effects 0.000 claims 19
- 239000000203 mixture Substances 0.000 claims 15
- 239000000090 biomarker Substances 0.000 claims 14
- 108091070501 miRNA Proteins 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 9
- 230000000692 anti-sense effect Effects 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- 101000904152 Homo sapiens Transcription factor E2F1 Proteins 0.000 claims 4
- 102100024026 Transcription factor E2F1 Human genes 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 238000002560 therapeutic procedure Methods 0.000 claims 4
- 108010040168 Bcl-2-Like Protein 11 Proteins 0.000 claims 3
- 102000001765 Bcl-2-Like Protein 11 Human genes 0.000 claims 3
- 206010060862 Prostate cancer Diseases 0.000 claims 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 3
- 239000003550 marker Substances 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 208000012895 Gastric disease Diseases 0.000 claims 2
- 239000003183 carcinogenic agent Substances 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 102000007372 Ataxin-1 Human genes 0.000 claims 1
- 108010032963 Ataxin-1 Proteins 0.000 claims 1
- 108010023936 Cofilin 2 Proteins 0.000 claims 1
- 102000011424 Cofilin 2 Human genes 0.000 claims 1
- 108010016788 Cyclin-Dependent Kinase Inhibitor p21 Proteins 0.000 claims 1
- 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 claims 1
- 102100022846 Histone acetyltransferase KAT2B Human genes 0.000 claims 1
- 102100033798 Homeobox protein aristaless-like 4 Human genes 0.000 claims 1
- 101001047006 Homo sapiens Histone acetyltransferase KAT2B Proteins 0.000 claims 1
- 101000779608 Homo sapiens Homeobox protein aristaless-like 4 Proteins 0.000 claims 1
- 101000994432 Homo sapiens Josephin-1 Proteins 0.000 claims 1
- 101001006886 Homo sapiens Krueppel-like factor 12 Proteins 0.000 claims 1
- 101000992394 Homo sapiens Oxysterol-binding protein-related protein 5 Proteins 0.000 claims 1
- 101001129705 Homo sapiens PH domain leucine-rich repeat-containing protein phosphatase 2 Proteins 0.000 claims 1
- 101000583178 Homo sapiens Pleckstrin homology domain-containing family M member 1 Proteins 0.000 claims 1
- 101000610204 Homo sapiens Poly(A) polymerase alpha Proteins 0.000 claims 1
- 101000709238 Homo sapiens Serine/threonine-protein kinase SIK1 Proteins 0.000 claims 1
- 101001098093 Homo sapiens Transcriptional repressor p66-beta Proteins 0.000 claims 1
- 101000837574 Homo sapiens Ubiquitin-conjugating enzyme E2 W Proteins 0.000 claims 1
- 101000964479 Homo sapiens Zinc finger and BTB domain-containing protein 18 Proteins 0.000 claims 1
- 101000781856 Homo sapiens Zinc finger protein 512B Proteins 0.000 claims 1
- 101000931371 Homo sapiens Zinc finger protein ZFPM2 Proteins 0.000 claims 1
- 102100032732 Josephin-1 Human genes 0.000 claims 1
- 102100027792 Krueppel-like factor 12 Human genes 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 101150079937 NEUROD1 gene Proteins 0.000 claims 1
- 108700020297 NeuroD Proteins 0.000 claims 1
- 102100032063 Neurogenic differentiation factor 1 Human genes 0.000 claims 1
- 102100032148 Oxysterol-binding protein-related protein 5 Human genes 0.000 claims 1
- 102100031136 PH domain leucine-rich repeat-containing protein phosphatase 2 Human genes 0.000 claims 1
- 102100030349 Pleckstrin homology domain-containing family M member 1 Human genes 0.000 claims 1
- 102100040155 Poly(A) polymerase alpha Human genes 0.000 claims 1
- 102100032771 Serine/threonine-protein kinase SIK1 Human genes 0.000 claims 1
- 102100037556 Transcriptional repressor p66-beta Human genes 0.000 claims 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 claims 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 claims 1
- 102100028700 Ubiquitin-conjugating enzyme E2 W Human genes 0.000 claims 1
- 102100040762 Zinc finger and BTB domain-containing protein 18 Human genes 0.000 claims 1
- 102100036647 Zinc finger protein 512B Human genes 0.000 claims 1
- 102100020996 Zinc finger protein ZFPM2 Human genes 0.000 claims 1
- 239000013068 control sample Substances 0.000 claims 1
- 230000001934 delay Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000001632 homeopathic effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 108091059456 miR-92-1 stem-loop Proteins 0.000 claims 1
- 108091084336 miR-92-2 stem-loop Proteins 0.000 claims 1
- 230000037361 pathway Effects 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000004614 tumor growth Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6744508P | 2008-02-28 | 2008-02-28 | |
| US61/067,445 | 2008-02-28 | ||
| PCT/US2009/035458 WO2009108853A1 (en) | 2008-02-28 | 2009-02-27 | MicroRNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF GASTRIC CANCER |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011516032A JP2011516032A (ja) | 2011-05-26 |
| JP2011516032A5 true JP2011516032A5 (enExample) | 2013-03-21 |
| JP5662166B2 JP5662166B2 (ja) | 2015-01-28 |
Family
ID=41016479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010548899A Expired - Fee Related JP5662166B2 (ja) | 2008-02-28 | 2009-02-27 | 胃癌の診断、予後診断及び治療のためのマイクロｒｎａに基づいた方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110034538A1 (enExample) |
| EP (2) | EP3064584A3 (enExample) |
| JP (1) | JP5662166B2 (enExample) |
| CN (1) | CN102007223B (enExample) |
| AU (1) | AU2009219190A1 (enExample) |
| CA (1) | CA2716906A1 (enExample) |
| WO (1) | WO2009108853A1 (enExample) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103820562B (zh) | 2005-08-01 | 2015-05-13 | 俄亥俄州立大学研究基金会 | 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 |
| CA2621441C (en) | 2005-09-12 | 2014-05-20 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |
| EP2484782B1 (en) | 2006-01-05 | 2015-11-18 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
| EP2502630B1 (en) | 2006-01-05 | 2015-03-11 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| CN101384273B (zh) | 2006-01-05 | 2013-07-10 | 俄亥俄州立大学研究基金会 | 胰腺内分泌和腺泡肿瘤中的微小rna表达异常 |
| EP2369013A1 (en) | 2006-03-20 | 2011-09-28 | The Ohio State University Research Foundation | Micro-RNA fingerprints during human megakaryocytopoiesis |
| EP2455493B1 (en) | 2006-07-13 | 2014-01-08 | The Ohio State University Research Foundation | Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases |
| CA2663027A1 (en) | 2006-09-19 | 2008-08-14 | The Ohio State University Research Foundation | Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181 |
| US8252538B2 (en) | 2006-11-01 | 2012-08-28 | The Ohio State University | MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma |
| CN103555825B (zh) | 2007-01-31 | 2015-09-30 | 俄亥俄州立大学研究基金会 | 用于急性髓细胞白血病(aml)的诊断、预后和治疗的基于微rna的方法和组合物 |
| CN101711287B (zh) | 2007-06-08 | 2016-04-27 | 由卫生与公众服务部代表的美利坚合众国政府 | 确定肝细胞癌亚型和检测肝癌干细胞的方法 |
| AU2008266014B2 (en) | 2007-06-15 | 2013-06-06 | The Ohio State University Research Foundation | Oncogenic ALL-1 fusion proteins for targeting drosha-mediated microRNA processing |
| CN101809169B (zh) | 2007-07-31 | 2013-07-17 | 俄亥俄州立大学研究基金会 | 通过靶向dnmt3a和dnmt3b恢复甲基化的方法 |
| EP2173908B1 (en) | 2007-08-03 | 2016-01-06 | The Ohio State University Research Foundation | Ultraconserved regions encoding ncrnas |
| CA2926831A1 (en) | 2007-08-22 | 2009-02-26 | The Ohio State University Research Foundation | Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias |
| CA2703707A1 (en) | 2007-10-26 | 2009-04-30 | The Ohio State University Research Foundation | Methods for identifying fragile histidine triad (fhit) interaction and uses thereof |
| CA2727633A1 (en) | 2008-06-11 | 2009-12-17 | Xin W. Wang | Use of mir-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy |
| EP2504452A4 (en) | 2009-11-23 | 2014-06-11 | Univ Ohio State Res Found | MATERIALS AND METHODS FOR INFLUENCING GROWTH, MIGRATION AND INVASION OF TUMOR CELLS |
| WO2012010584A1 (en) * | 2010-07-20 | 2012-01-26 | Febit Holding Gmbh | Complex mirna sets as novel biomarkers for gastric cancer |
| CN103648505B (zh) | 2010-11-12 | 2016-09-28 | 俄亥俄州立大学研究基金会 | 与微rna-21、错配修复和结肠直肠癌相关的材料和方法 |
| BR112013011942A2 (pt) | 2010-11-15 | 2016-11-01 | Univ Michigan | formulação, forma de dosagem de droga para administração transmucosa oral, sistema transmucoso de fornecimento de droga, método de tratamento e profilaxia de uma doença ou distúrbio, método de tratamento, formulação, método para tratamento ou prevenção de carcinoma de célula escamosa de cabeça e pescoço (hnscc), método para quimioprevenção de um câncer oral ou condição pré-cancerosa, método para aumentar a concentração de uma composição de retinida, método de tratamento e profilaxia de uma doença ou condição, método de ratamento de um sujeito apresentando uma condição médica sintomática, método de tratamento de um câncer oral ou condição pré-cancerosa num paciente, método para fazer um sistema de fornecimento de droga bucal, método para aumentar a liberação e permeação de uma composição de retinida. |
| SG182016A1 (en) * | 2010-12-14 | 2012-07-30 | Univ Singapore | Method of detecting resistance to cancer therapy |
| CA2828772A1 (en) | 2011-03-07 | 2012-09-13 | The Ohio State University | Mutator activity induced by microrna-155 (mir-155) links inflammation and cancer |
| EP2699666B1 (en) * | 2011-04-18 | 2016-10-05 | DiamiR, LLC | miRNA-BASED UNIVERSAL SCREENING TEST (UST) |
| US8703425B2 (en) * | 2011-09-12 | 2014-04-22 | The Chinese University Of Hong Kong | Biomarker for gastric cancer |
| GB201117482D0 (en) * | 2011-10-11 | 2011-11-23 | Univ Dundee | Targetiing of miRNA precursors |
| EP2766500A4 (en) | 2011-10-14 | 2015-10-14 | Univ Ohio State | METHOD AND MATERIALS IN CONNECTION WITH EGG CANCER |
| CA2859430A1 (en) | 2011-12-13 | 2013-06-20 | Ohio State Innovation Foundation | Methods and compositions related to mir-21 and mir-29a, exosome inhibition, and cancer metastasis |
| US8859202B2 (en) | 2012-01-20 | 2014-10-14 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
| WO2014028762A1 (en) * | 2012-08-15 | 2014-02-20 | University Of Virginia Patent Foundation | Compositions and methods for treating peripheral arterial disease |
| WO2014097875A1 (ja) * | 2012-12-20 | 2014-06-26 | 国立大学法人鳥取大学 | 新規の脱分化誘導方法を用いた多能性幹細胞化 |
| CN104013975A (zh) * | 2014-06-16 | 2014-09-03 | 山东大学 | Fbxo31基因及其相关产物在制备胃癌治疗药物中的应用 |
| US10597727B2 (en) * | 2014-06-16 | 2020-03-24 | Toray Industries, Inc. | Stomach cancer detection kit or device, and detection method |
| KR102237960B1 (ko) | 2014-08-07 | 2021-04-08 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 위암 진단용 microrna 바이오마커 |
| CN104293923A (zh) * | 2014-09-19 | 2015-01-21 | 浙江大学 | 荧光定量PCR检测组织中miR-100含量的试剂盒及其应用 |
| CN106591428B (zh) * | 2016-09-23 | 2021-06-11 | 宁波大学 | 一种胃癌新型分子标记物hsa_circ_0001017的检测及应用 |
| CN106636334B (zh) * | 2016-10-09 | 2020-07-03 | 山东大学 | microRNA标志物组及其在制备检测胃癌淋巴结转移试剂盒中的应用 |
| CN106755513B (zh) * | 2017-02-08 | 2018-10-19 | 泰山医学院 | 一种胃癌的lncRNA标志物 |
| EP3600277A4 (en) * | 2017-03-31 | 2020-10-28 | The Curators of the University of Missouri | COMPOSITIONS FOR THE TREATMENT OF DRUG-RESISTANT TUMORS AND THEIR USE PROCEDURES |
| CN107217055B (zh) * | 2017-06-26 | 2019-01-18 | 生工生物工程（上海）股份有限公司 | 一种癌症诊断芯片及其试剂盒 |
| CN107641653B (zh) * | 2017-10-20 | 2021-02-19 | 南方医科大学南方医院 | Macc1-as1探针在制备用于预测胃癌临床预后的诊断试剂中的应用 |
| CN108546757B (zh) * | 2018-03-05 | 2021-09-07 | 上海长海医院 | Zfpm2-as1在制备胃癌诊断试剂或试剂盒中的应用 |
| KR102100124B1 (ko) * | 2018-08-31 | 2020-05-15 | 한국표준과학연구원 | 질량 분석법을 이용한 생체 분자의 고감도 및 고특이적 검출 방법 |
| WO2020130944A1 (en) * | 2018-12-19 | 2020-06-25 | Agency For Science, Technology And Research | Method of diagnosing gastric cancers using micrornas |
| CN117683885A (zh) * | 2019-04-30 | 2024-03-12 | 觅瑞实验室私人有限公司 | 一种检测胃癌的miRNA标志物组合及试剂盒 |
| CN111471764B (zh) * | 2019-12-27 | 2023-09-15 | 陈锦飞 | 一种用于筛查或辅助诊断胃癌的生物标志物组合及其试剂盒和应用 |
| CN111139299B (zh) * | 2020-01-08 | 2021-12-17 | 浙江大学 | Josd2蛋白在制备治疗恶性肿瘤药物中的应用 |
| CN111471683B (zh) * | 2020-04-15 | 2021-09-07 | 湖南省科域生物医药科技有限公司 | miR-93-5p作为诊断和治疗胃癌标志物的应用 |
| CN114678121B (zh) * | 2022-05-30 | 2022-09-09 | 上海芯超生物科技有限公司 | 一种hp球形变诊断模型的构建方法及系统 |
| WO2025245056A1 (en) * | 2024-05-20 | 2025-11-27 | City Of Hope | Gastric cancer rna biomarkers and uses thereof |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1837495A (en) * | 1994-10-13 | 1996-05-06 | Horus Therapeutics, Inc. | Computer assisted methods for diagnosing diseases |
| US6303323B1 (en) * | 1997-10-21 | 2001-10-16 | Cancer Research Campaign Technology Limited | Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies |
| US6891031B2 (en) * | 2000-02-18 | 2005-05-10 | The Regents Of The University Of California | Coordinate cytokine regulatory sequences |
| AU2002360377A1 (en) * | 2001-11-09 | 2003-05-19 | The Ohio State University Research Foundation | Baalc expression as a diagnostic marker for acute leukemia |
| WO2003069853A1 (en) * | 2002-02-12 | 2003-08-21 | Nokia Corporation | Method for controlling data transmission, and data transmission system |
| WO2004071464A2 (en) * | 2003-02-12 | 2004-08-26 | Johns Hopkins University School Of Medicine | Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| WO2006031210A1 (en) * | 2003-05-29 | 2006-03-23 | Board Of Regents, The University Of Texas Systems | Jabi as a prognostic marker and a therapeutic target for human cancer |
| US8106180B2 (en) * | 2003-08-07 | 2012-01-31 | Whitehead Institute For Biomedical Research | Methods and products for expression of micro RNAs |
| US20050164252A1 (en) * | 2003-12-04 | 2005-07-28 | Yeung Wah Hin A. | Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell |
| US20060134639A1 (en) * | 2004-04-06 | 2006-06-22 | Huffel Christophe V | Method for the determination of cellular transcriptional regulation |
| CN101056991A (zh) * | 2004-04-20 | 2007-10-17 | 基因耐克生物医学制品有限公司 | 检测ncRNA的方法 |
| EP2290073A3 (en) * | 2004-05-28 | 2011-08-31 | Asuragen, Inc. | Methods and compositions involving microRNA |
| WO2006007529A2 (en) * | 2004-07-01 | 2006-01-19 | University Of Pittsburgh Of The Commonwealth System For Higher Education | Immunosuppressive exosomes |
| EP2338994B1 (en) * | 2004-09-02 | 2014-03-19 | Yale University | Regulation of oncogenes by microRNAs |
| US7642348B2 (en) * | 2004-10-04 | 2010-01-05 | Rosetta Genomics Ltd | Prostate cancer-related nucleic acids |
| US7571055B2 (en) * | 2004-10-13 | 2009-08-04 | Regents Of The University Of Minnesota | Systemic lupus erythematosus |
| CA2857878A1 (en) * | 2004-11-12 | 2006-12-28 | Asuragen, Inc. | Methods and compositions involving mirna and mirna inhibitor molecules |
| US8071306B2 (en) * | 2005-01-25 | 2011-12-06 | Merck Sharp & Dohme Corp. | Methods for quantitating small RNA molecules |
| EP1856286A2 (en) * | 2005-02-11 | 2007-11-21 | Wisconsin Alumni Research Foundation | Mir-155 assay |
| US20070213292A1 (en) * | 2005-08-10 | 2007-09-13 | The Rockefeller University | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| US20070092882A1 (en) * | 2005-10-21 | 2007-04-26 | Hui Wang | Analysis of microRNA |
| US8445198B2 (en) * | 2005-12-01 | 2013-05-21 | Medical Prognosis Institute | Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| CN101384273B (zh) * | 2006-01-05 | 2013-07-10 | 俄亥俄州立大学研究基金会 | 胰腺内分泌和腺泡肿瘤中的微小rna表达异常 |
| EP2502630B1 (en) * | 2006-01-05 | 2015-03-11 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| EP2484782B1 (en) * | 2006-01-05 | 2015-11-18 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
| DK2666859T3 (en) * | 2006-04-03 | 2019-04-08 | Roche Innovation Ct Copenhagen As | PHARMACEUTICAL COMPOSITION CONTAINING ANTI-miRNA ANTISENSE OLIGONUCLEOTIDES |
| EP2455493B1 (en) * | 2006-07-13 | 2014-01-08 | The Ohio State University Research Foundation | Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases |
| JP2010510964A (ja) * | 2006-09-19 | 2010-04-08 | アシュラジェン インコーポレイテッド | 治療的介入の標的としての、ｍｉＲ−１５、ｍｉＲ−２６、ｍｉＲ−３１、ｍｉＲ−１４５、ｍｉＲ−１４７、ｍｉＲ−１８８、ｍｉＲ−２１５、ｍｉＲ−２１６、ｍｉＲ−３３１、ｍｍｕ−ｍｉＲ−２９２−３ｐによって調節される遺伝子および経路 |
| WO2008073920A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-21 regulated genes and pathways as targets for therapeutic intervention |
| ATE553196T1 (de) * | 2007-02-27 | 2012-04-15 | Rosetta Genomics Ltd | Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod |
| JP5331714B2 (ja) * | 2007-03-16 | 2013-10-30 | コヴァルクス・アーゲー | タンパク質複合体をターゲティングする薬物候補の直接質量分析 |
| EP2613149B1 (en) * | 2007-07-25 | 2014-09-17 | University Of Louisville Research Foundation, Inc. | Exosome-associated microRNA as a diagnostic marker |
| CA2926831A1 (en) * | 2007-08-22 | 2009-02-26 | The Ohio State University Research Foundation | Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias |
| US20090239818A1 (en) * | 2007-09-07 | 2009-09-24 | Cheng Jin Q | Effective treatment of ovarian cancer using triciribine and related compounds |
| WO2009044899A1 (ja) * | 2007-10-03 | 2009-04-09 | Kyowa Hakko Kirin Co., Ltd. | 細胞の増殖を制御する核酸 |
| ES2463665T3 (es) * | 2007-10-04 | 2014-05-28 | Stella Aps | Tratamiento de combinación para el tratamiento de infección por virus de la hepatitis C |
| CA2704043C (en) * | 2007-10-29 | 2018-09-18 | Rosetta Genomics Ltd. | Targeting micrornas for the treatment of liver cancer |
| ES2936256T3 (es) * | 2008-02-01 | 2023-03-15 | Massachusetts Gen Hospital | Uso de microvesículas en el diagnóstico, y pronóstico de enfermedades y afecciones médicas |
| US20110054009A1 (en) * | 2008-02-28 | 2011-03-03 | The Ohio State University Research Foundation | MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders |
| WO2009111375A2 (en) * | 2008-03-01 | 2009-09-11 | Abraxis Bioscience, Llc | Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas |
| US20090233297A1 (en) * | 2008-03-06 | 2009-09-17 | Elizabeth Mambo | Microrna markers for recurrence of colorectal cancer |
| WO2009147525A1 (en) * | 2008-06-04 | 2009-12-10 | Karolinska Institutet Innovations Ab | Skin cancer associated micrornas |
| US20100021734A1 (en) * | 2008-07-22 | 2010-01-28 | Covalent Materials Corporation | Ceramic particles and producing method thereof |
| KR101031305B1 (ko) * | 2008-07-23 | 2011-04-29 | 국립암센터 | 마이크로ｒｎａ-21 저해제를 포함하는 방사선 민감성증진용 조성물 |
| US20100179213A1 (en) * | 2008-11-11 | 2010-07-15 | Mirna Therapeutics, Inc. | Methods and Compositions Involving miRNAs In Cancer Stem Cells |
| EP2373815A4 (en) * | 2008-12-05 | 2012-09-26 | Univ Ohio State Res Found | METHODS AND COMPOSITIONS BASED ON MICROARN FOR THE DIAGNOSIS AND TREATMENT OF OVARIAN CANCER |
-
2009
- 2009-02-27 CA CA2716906A patent/CA2716906A1/en not_active Abandoned
- 2009-02-27 US US12/919,893 patent/US20110034538A1/en not_active Abandoned
- 2009-02-27 EP EP16165519.6A patent/EP3064584A3/en not_active Withdrawn
- 2009-02-27 JP JP2010548899A patent/JP5662166B2/ja not_active Expired - Fee Related
- 2009-02-27 AU AU2009219190A patent/AU2009219190A1/en not_active Abandoned
- 2009-02-27 WO PCT/US2009/035458 patent/WO2009108853A1/en not_active Ceased
- 2009-02-27 EP EP09713926.5A patent/EP2257647B1/en not_active Not-in-force
- 2009-02-27 CN CN200980112966.1A patent/CN102007223B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Duforestel et al. | Glyphosate primes mammary cells for tumorigenesis by reprogramming the epigenome in a TET3-dependent manner | |
| Huang et al. | SET and MYND domain containing protein 3 in cancer | |
| JP2011517932A5 (enExample) | ||
| ES2742840T3 (es) | Biomarcadores de micro-ARN para identificar el riesgo y/o diagnosticar tumor pulmonar | |
| Chen et al. | H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma | |
| Jiang et al. | Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma | |
| Jin et al. | Vitamin D inhibits the proliferation of Oral Squamous Cell Carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway | |
| Meng et al. | Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer | |
| ES2772701T3 (es) | Uso de nucleosomas libres de células como biomarcadores en muestras de esputo | |
| Suri et al. | Recent advances in minimally invasive biomarkers of OSCC: from generalized to personalized approach | |
| Cheng et al. | CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis | |
| Pan et al. | miR-29b-3p increases radiosensitivity in stemness cancer cells via modulating oncogenes axis | |
| Chen et al. | Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation | |
| Wang et al. | MicroRNA-374b inhibits the tumor growth and promotes apoptosis in non-small cell lung cancer tissue through the p38/ERK signaling pathway by targeting JAM-2 | |
| Cai et al. | High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma | |
| Sun et al. | Role of transgelin-2 in diabetes-associated pancreatic ductal adenocarcinoma | |
| Okada et al. | Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma | |
| Li et al. | DNA demethylase TET2-mediated reduction of HADHB expression contributes to cadmium-induced malignant progression of colorectal cancer | |
| Zhang et al. | HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib | |
| Zheng et al. | MRTO4 enhances glycolysis to facilitate HCC progression by inhibiting ALDOB | |
| Wu et al. | PHLPP2 is regulated by competing endogenous RNA network in pathogenesis of colon cancer | |
| Ding et al. | TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling | |
| PT1853721E (pt) | Método para determinar a sensibilidade a inibidores de chk1 | |
| Saller et al. | A microRNA signature identifies patients at risk of Barrett esophagus progression to dysplasia and cancer | |
| CN116855608B (zh) | Cited1在肺癌诊断、治疗及预后预测中的应用 |